Iridex (IRIX) FCF Margin Growth (3y) (2014 - 2026)
Iridex (IRIX) FCF Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -2,196.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2,679.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -20.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -472.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Iridex | 15.93 Mn | 11.33 Mn | 4.74 Mn | 889.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 889.00 |
| Jan 3, 2026 | 1,725.00 |
| Sep 27, 2025 | 869.00 |
| Jun 28, 2025 | 1,844.00 |
| Mar 29, 2025 | 1,564.00 |
| Dec 28, 2024 | -4,801.00 |
| Mar 30, 2024 | -11,340.00 |
| Sep 30, 2023 | -2,079.00 |
| Jul 1, 2023 | 2,438.00 |
| Apr 1, 2023 | -507.00 |
| Dec 31, 2022 | -954.00 |
| Oct 1, 2022 | 601.00 |
| Jul 2, 2022 | -804.00 |
| Apr 2, 2022 | 1,126.00 |
| Jan 1, 2022 | 5,825.00 |
| Apr 3, 2021 | 12,833.00 |
| Sep 26, 2020 | 1,865.00 |
| Jun 27, 2020 | -4,116.00 |
| Mar 28, 2020 | 274.00 |
| Dec 28, 2019 | 323.00 |